Skip to content
Fiscal Receipts

Senate LDA lobbying filing

CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION)

Registrant: KOUNTOUPES DENHAM CARR & REID, LLC Year: 2024 Period: Fourth Quarter Type: Q4

View on lda.senate.gov ↗

Reported income

$60.0K

Reported expenses

not reported

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

Lobbying activities3

  • DefenseDEF

    Issues related to drug shortages and stockpile issues at the U.S. Department of Defense.

  • Health IssuesHCR

    Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act. Issues related to cybersecurity. Issues related to drug distribution and access. Issues related to the reauthorization of the Pandemic and All Hazards Preparedness Act.

  • PharmacyPHA

    Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug pricing transparency. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R.1770/S. 2477, The Equitable Community Access to Pharmacist Services Act.

Lobbyists4

  • JULIE CARR
  • LESLIE ZELENKO
  • LORI DENHAM
  • MARY BEAL

Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.